Skip to content
Clinical Trials – home
DenmarkBack to Denmark

Clinical trials in Aarhus

634 clinical trials in Aarhus, Denmark across 5 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

DenmarkOur site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)
Aarhus at a glance
634
clinical trials
  • Research sites5
Type of trial
Recruitment status
Quick filters

634 trials in Aarhus

Open in trial search
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Azd5004
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Enfortumab Vedotin
  • Sponsor:Eli Lilly & Co.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Barzolvolimab
  • Sponsor:Celldex Therapeutics Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Bevacizumab
  • Sponsor:Amgen Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dazodalibep
  • Sponsor:Amgen Inc.

Psoriasis

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Darovasertib
  • Sponsor:Ideaya Biosciences Inc.
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Docetaxel
  • Sponsor:Ferring Pharmaceuticals A/S
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Other cities in Denmark

The busiest research cities in the country

All 47 cities in Denmark

Clinical research in Aarhus

What the registry says about research in the country

01 Respiratory & Pulmonary Research

Clinical investigations focusing on idiopathic pulmonary fibrosis and innovative treatments for respiratory conditions. Studies include assessment of vital capacity changes and evaluation of new therapeutic approaches.

  • Pulmonary Function Testing
  • Respiratory Disease Management
  • Treatment Efficacy Studies
02 Oncology & Cancer Research

Groundbreaking trials examining treatments for endometrial carcinoma and hepatocellular carcinoma, utilizing advanced imaging techniques and combination therapies.

  • Immunotherapy Combinations
  • Early Cancer Detection
  • Targeted Therapies
03 Neurological Disorders

Studies investigating amyotrophic lateral sclerosis and neurological conditions using innovative MRI techniques and metabolic imaging. Research includes assessment of chronic inflammatory demyelinating polyneuropathy.

  • Metabolic Imaging
  • Neurodegeneration
  • Treatment Response
04 Preventive Medicine

Vaccination studies targeting meningococcal infection and respiratory syncytial virus, with particular focus on maternal and infant health protection.

  • Vaccine Development
  • Immunogenicity Assessment
  • Maternal-Infant Protection
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).